Pharmaceutical

KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the…

1 month ago

ISS National Lab Publication Highlights Groundbreaking Physical Science Research in Space

NSF Collaboration Opens New Avenues for Scientific Discovery Benefiting Humanity and Earth's Economy KENNEDY SPACE CENTER, Fla., Nov. 25, 2024…

1 month ago

Life Sciences Leaders Unite at BioFlorida’s Thriving Annual Conference

Annual Conference spotlights the state's successes while also solidifying a course for the future ORLANDO, Fla., Nov. 25, 2024 /PRNewswire/…

1 month ago

Medicure Reports Financial Results For Quarter Ended September 30, 2024

WINNIPEG, MB / ACCESSWIRE / November 25, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused…

1 month ago

Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings

REDWOOD CITY, CA / ACCESSWIRE / November 25, 2024 / Juva Life Inc. (CSE:JUVA)(OTC PINK:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a…

1 month ago

Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China

NEW YORK, Nov. 25, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology,…

1 month ago

Lakeside Strengthens Market Position in China’s Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts

ITASCA, Ill., Nov. 25, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border…

1 month ago

Seven Top Pharma Companies Adopt PhaseV’s Machine Learning Technology for Drug Development

Within Two Years of Hitting the Market, PhaseV Solutions are Being Used to Guide Adaptive Trials, Precision Medicine, and Indication…

1 month ago

Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference

SAN FRANCISCO, CA / ACCESSWIRE / November 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the…

1 month ago

Lexaria’s GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / November 25, 2024…

1 month ago